Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Construction In Progress: HK$24 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03613 Beijing Tong Ren Tang Chinese Medicine Co Ltd HKSE:03613
89 GF Score
Price HK$6.90
GF Value HK$9.64
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Beijing Tong Ren Tang Chinese Medicine Co Construction In Progress?

Beijing Tong Ren Tang Chinese Medicine Co HKSE:03613 -1.85% 89 Construction In Progress is HK$24 Mil as of Dec. 2025. GuruFocus rates HKSE:03613 with a GF Score™ of 89/100 and a GF Value™ of HK$9.64 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Beijing Tong Ren Tang Chinese Medicine Co's quarterly construction in progress declined from Dec. 2024 (HK$16 Mil) to Jun. 2025 (HK$0 Mil) but then increased from Jun. 2025 (HK$0 Mil) to Dec. 2025 (HK$24 Mil).

Beijing Tong Ren Tang Chinese Medicine Co's annual construction in progress increased from Dec. 2023 (HK$11 Mil) to Dec. 2024 (HK$16 Mil) and increased from Dec. 2024 (HK$16 Mil) to Dec. 2025 (HK$24 Mil).

Beijing Tong Ren Tang Chinese Medicine Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Beijing Tong Ren Tang Chinese Medicine Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tong Ren Tang Chinese Medicine Co Construction In Progress Chart

Beijing Tong Ren Tang Chinese Medicine Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.25 11.72 11.19 16.45 24.36

Beijing Tong Ren Tang Chinese Medicine Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.19 15.77 16.45 0.00 24.36
HKSE:03613
89GF Score
Beijing Tong Ren Tang Chinese Medicine Co Ltd HKSE:03613
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Tong Ren Tang Chinese Medicine Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of HK$24 Mil mean?
Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) has a Construction In Progress of HK$24 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Beijing Tong Ren Tang Chinese Medicine Co and its competitors.
Is Beijing Tong Ren Tang Chinese Medicine Co's Construction In Progress too high?
Beijing Tong Ren Tang Chinese Medicine Co's current Construction In Progress is HK$24 Mil. Overall, Beijing Tong Ren Tang Chinese Medicine Co has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tong Ren Tang Chinese Medicine Co's Construction In Progress compare to ZTS and UTHR?
Beijing Tong Ren Tang Chinese Medicine Co's Construction In Progress of HK$24 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Beijing Tong Ren Tang Chinese Medicine Co and its competitors. Beijing Tong Ren Tang Chinese Medicine Co's current Construction In Progress is HK$24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tong Ren Tang Chinese Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$9.64, compared to a current price of HK$6.90 — trading 28.4% below its estimated fair value. The current Construction In Progress is HK$24 Mil. Beijing Tong Ren Tang Chinese Medicine Co's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613), the current Construction In Progress is HK$24 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tong Ren Tang Chinese Medicine Co stock appears to be undervalued. The current stock price of HK$6.90 is trading 28.4% below its estimated GF Value™ of HK$9.64. GuruFocus considers Beijing Tong Ren Tang Chinese Medicine Co to be Modestly Undervalued.

Key valuation signals for HKSE:03613:

  • Construction In Progress: HK$24 Mil
  • GF Value™: HK$9.64 vs. price of HK$6.90 (28.4% below fair value)
  • GF Score™: 89/100 with 3 warning signs

No single metric tells the full story. See the HKSE:03613 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Tong Ren Tang Chinese Medicine Co Business Description

Other Exchanges TQR:Germany
Address Convention Plaza, 1 Harbour Road, Room 1405-1409, Office Tower, Wanchai, Hong Kong, HKG
Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products; Chinese Mainland (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Chinese Mainland and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd; and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.
89GF Score

Get the complete analysis for HKSE:03613

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.90
Price
HK$9.64
GF Value